SlideShare a Scribd company logo
1 of 12
Download to read offline
Progress Report for NIR
Spectroscopy Studies
November 7, 2000
Tania Khan
Mohammed Asif, M.D.
Silvio Litovsky, M.D.
Morteza Naghavi, M.D.
Progress
• New probe design being worked out with Multimode to
improve NIR signal 10/31- current
– Data analysis of all prior spectra required in progress
– Characterize new light source in same manner (configurations,
reference standards, sampling methods)
– Must send out on order before AHA next week
• Ongoing difficulties in working on a depth penetration
study
• Tissue phantom study needed for pH
• Experimental setup issues: time, temperature,
physiological maintenance, digital camera, etc.
Plaque 10/31
1
2
3
4
5
2.5 cm
1 cm
Data
1
2
3
4
5
0.1 mm thick
pH 7.63
34.6°C0.3 mm thick
pH 8.08
32.9°C
0.4 mm thick
pH 7.41
32.5°C
0.6 mm thick
pH 8.08
34.2°C
Thrombosed/Calicified
area? 0.6 x 0.5 cm
0.7 mm thick
pH 8.25
32.1°C
Calcified hard area
4x
10x
40x
HA-2-1
-0.4
-0.3
-0.2
-0.1
0.0
0.1
0.2
0.3
400 600 800 1000
wavelength
absorbance
HA-2-2
-0.4
-0.2
0.0
0.2
0.4
0.6
0.8
1.0
400 500 600 700 800 900 1000 1100
wavelength
absorbance
4x
10x
40x
HA-2-3
-0.4
-0.2
0.0
0.2
0.4
0.6
0.8
400 500 600 700 800 900 1000 1100
wavelength
absorbance
4x
10x
40x
HA-2-4
-0.4
-0.2
0.0
0.2
0.4
0.6
0.8
400 500 600 700 800 900 1000 1100
wavelength
absorbance
4x
40x
Very calcified,
Should have put in De-Cal
Solution more than 1 hr.
HA-2-5
-0.4
-0.2
0.0
0.2
0.4
0.6
0.8
1.0
1.2
400 500 600 700 800 900 1000 1100
wavelength
absorbance
4x
40x
10x
All Areas
-0.4
-0.2
0.0
0.2
0.4
0.6
0.8
1.0
1.2
400 500 600 700 800 900 1000 1100
wavelength
absorbance
VIS HA-2-5 I-M VIS HA-2-4 HA-2-3 VIS HA-2-2 HA-2-1
Fibrosis, necrosis, calcifications are all qualitative
Only 5 points, no pH correlation can be made
Environmental condition stabilization needs to be improved
Quantify degree of surface roughness for spectra collection
CONCLUSIONS
• New light source changes relative absorbance
– Light source must be characterized (configurations, reference
standards, etc.)
• Tissue penetration unresolved with histology
– Penetration study must be completed with new light source
• Histology and other experimental setup issues
unresolved; temperature, other physiological,
morphological variables
• Need quantitative measurements of histology
– Cap thickness, size of necrotic core, cell density, etc.
• New probe needed to reach wavelengths above 1900
nm (lactate region) ; spectrometer OK
– Currently being designed with help from Mulitmode Inc.
PRIORITIES
1. Analyze data to see what would be best to
incorporate in a new probe design to get better
spectra out past 1900 nm (water bands, lactate
bands, cholesterol bands)
2. Characterize light source
3. Conduct depth penetration study
4. Conduct tissue phantom study (pH, lactate,
thrombus?)
5. Fix experimental setup issues
6. Start tissue pH spectroscopy of human carotid
plaques study

More Related Content

Viewers also liked

220 statin therapy and coronary calcification
220 statin therapy and coronary calcification220 statin therapy and coronary calcification
220 statin therapy and coronary calcificationSHAPE Society
 
238 carotid array coil
238 carotid array coil238 carotid array coil
238 carotid array coilSHAPE Society
 
110 electron beam tomography
110 electron beam tomography110 electron beam tomography
110 electron beam tomographySHAPE Society
 
191 spio and t2 effect
191 spio and t2 effect191 spio and t2 effect
191 spio and t2 effectSHAPE Society
 
202 vp watch of the year 2002
202 vp watch of the year 2002202 vp watch of the year 2002
202 vp watch of the year 2002SHAPE Society
 
167 plaque p h heterogeneity in physiological media
167 plaque p h heterogeneity in physiological media167 plaque p h heterogeneity in physiological media
167 plaque p h heterogeneity in physiological mediaSHAPE Society
 
No correlation and low agreement of imaging and inflammatory atherosclerosis’...
No correlation and low agreement of imaging and inflammatory atherosclerosis’...No correlation and low agreement of imaging and inflammatory atherosclerosis’...
No correlation and low agreement of imaging and inflammatory atherosclerosis’...SHAPE Society
 
3rd vulnerable plaque rumberger 3 16-02 1
3rd vulnerable plaque rumberger 3 16-02 13rd vulnerable plaque rumberger 3 16-02 1
3rd vulnerable plaque rumberger 3 16-02 1SHAPE Society
 
230 plaque crp or myocardial crp
230 plaque crp or myocardial crp230 plaque crp or myocardial crp
230 plaque crp or myocardial crpSHAPE Society
 
204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques
204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques
204 prevalence of inflammatory cells in non ruptured atherosclerotic plaquesSHAPE Society
 
1688 azadpour 3 12 02
1688 azadpour 3 12 021688 azadpour 3 12 02
1688 azadpour 3 12 02SHAPE Society
 
3rd vulnerable plaque rumberger 3 16-02 1
3rd vulnerable plaque rumberger 3 16-02 13rd vulnerable plaque rumberger 3 16-02 1
3rd vulnerable plaque rumberger 3 16-02 1SHAPE Society
 
089 intravascular magnetic resonance imaging
089 intravascular magnetic resonance imaging089 intravascular magnetic resonance imaging
089 intravascular magnetic resonance imagingSHAPE Society
 
249 the most cost effective therapy
249 the most cost effective therapy249 the most cost effective therapy
249 the most cost effective therapySHAPE Society
 
219 coronary autoregulation in vivo
219 coronary autoregulation in vivo219 coronary autoregulation in vivo
219 coronary autoregulation in vivoSHAPE Society
 
508 search for genomic and proteomic risk factors and protective factors asso...
508 search for genomic and proteomic risk factors and protective factors asso...508 search for genomic and proteomic risk factors and protective factors asso...
508 search for genomic and proteomic risk factors and protective factors asso...SHAPE Society
 
218 pharmacologic stabilization of vulnerable plaque
218 pharmacologic stabilization of vulnerable plaque218 pharmacologic stabilization of vulnerable plaque
218 pharmacologic stabilization of vulnerable plaqueSHAPE Society
 

Viewers also liked (20)

220 statin therapy and coronary calcification
220 statin therapy and coronary calcification220 statin therapy and coronary calcification
220 statin therapy and coronary calcification
 
238 carotid array coil
238 carotid array coil238 carotid array coil
238 carotid array coil
 
110 electron beam tomography
110 electron beam tomography110 electron beam tomography
110 electron beam tomography
 
191 spio and t2 effect
191 spio and t2 effect191 spio and t2 effect
191 spio and t2 effect
 
Acc 2005-1, v pl-vp
Acc 2005-1, v pl-vpAcc 2005-1, v pl-vp
Acc 2005-1, v pl-vp
 
175 tissue contrast
175 tissue contrast175 tissue contrast
175 tissue contrast
 
202 vp watch of the year 2002
202 vp watch of the year 2002202 vp watch of the year 2002
202 vp watch of the year 2002
 
167 plaque p h heterogeneity in physiological media
167 plaque p h heterogeneity in physiological media167 plaque p h heterogeneity in physiological media
167 plaque p h heterogeneity in physiological media
 
No correlation and low agreement of imaging and inflammatory atherosclerosis’...
No correlation and low agreement of imaging and inflammatory atherosclerosis’...No correlation and low agreement of imaging and inflammatory atherosclerosis’...
No correlation and low agreement of imaging and inflammatory atherosclerosis’...
 
512 low t3 syndrome
512 low t3 syndrome512 low t3 syndrome
512 low t3 syndrome
 
3rd vulnerable plaque rumberger 3 16-02 1
3rd vulnerable plaque rumberger 3 16-02 13rd vulnerable plaque rumberger 3 16-02 1
3rd vulnerable plaque rumberger 3 16-02 1
 
230 plaque crp or myocardial crp
230 plaque crp or myocardial crp230 plaque crp or myocardial crp
230 plaque crp or myocardial crp
 
204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques
204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques
204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques
 
1688 azadpour 3 12 02
1688 azadpour 3 12 021688 azadpour 3 12 02
1688 azadpour 3 12 02
 
3rd vulnerable plaque rumberger 3 16-02 1
3rd vulnerable plaque rumberger 3 16-02 13rd vulnerable plaque rumberger 3 16-02 1
3rd vulnerable plaque rumberger 3 16-02 1
 
089 intravascular magnetic resonance imaging
089 intravascular magnetic resonance imaging089 intravascular magnetic resonance imaging
089 intravascular magnetic resonance imaging
 
249 the most cost effective therapy
249 the most cost effective therapy249 the most cost effective therapy
249 the most cost effective therapy
 
219 coronary autoregulation in vivo
219 coronary autoregulation in vivo219 coronary autoregulation in vivo
219 coronary autoregulation in vivo
 
508 search for genomic and proteomic risk factors and protective factors asso...
508 search for genomic and proteomic risk factors and protective factors asso...508 search for genomic and proteomic risk factors and protective factors asso...
508 search for genomic and proteomic risk factors and protective factors asso...
 
218 pharmacologic stabilization of vulnerable plaque
218 pharmacologic stabilization of vulnerable plaque218 pharmacologic stabilization of vulnerable plaque
218 pharmacologic stabilization of vulnerable plaque
 

Similar to 103100

151 performance of a localized fiber optic
151 performance of a localized fiber optic151 performance of a localized fiber optic
151 performance of a localized fiber opticSHAPE Society
 
The performance of portable mid-infrared spectroscopy for the prediction of s...
The performance of portable mid-infrared spectroscopy for the prediction of s...The performance of portable mid-infrared spectroscopy for the prediction of s...
The performance of portable mid-infrared spectroscopy for the prediction of s...ExternalEvents
 
Chemical Analysis Facility
Chemical Analysis FacilityChemical Analysis Facility
Chemical Analysis Facilitychristinejcardin
 
Item 9 Standard Protocol and Scheme for Measuring Soil Spectroscopy under the...
Item 9 Standard Protocol and Scheme for Measuring Soil Spectroscopy under the...Item 9 Standard Protocol and Scheme for Measuring Soil Spectroscopy under the...
Item 9 Standard Protocol and Scheme for Measuring Soil Spectroscopy under the...Soils FAO-GSP
 
محاضره نانو -دكتور عمر نور
محاضره نانو -دكتور عمر نور محاضره نانو -دكتور عمر نور
محاضره نانو -دكتور عمر نور AymanHassan15
 
Recent advances in endodontics
Recent advances in endodontics Recent advances in endodontics
Recent advances in endodontics Hope Inegbenosun
 
How to give a written presentation. Conferences: Oral and poster communicatio...
How to give a written presentation.Conferences: Oral and poster communicatio...How to give a written presentation.Conferences: Oral and poster communicatio...
How to give a written presentation. Conferences: Oral and poster communicatio...EDUTIC_aulas_digitales
 
Measuring Nitrous Oxide & Methane from Feedyard Surfaces - the NFT-NSS Chambe...
Measuring Nitrous Oxide & Methane from Feedyard Surfaces - the NFT-NSS Chambe...Measuring Nitrous Oxide & Methane from Feedyard Surfaces - the NFT-NSS Chambe...
Measuring Nitrous Oxide & Methane from Feedyard Surfaces - the NFT-NSS Chambe...LPE Learning Center
 
Webinar jenck id_sustancias
Webinar jenck id_sustanciasWebinar jenck id_sustancias
Webinar jenck id_sustanciasMaxi Pavon
 
Application of electronic nose for rapid diagnosis of tuberculosis
Application  of  electronic nose  for  rapid  diagnosis  of tuberculosisApplication  of  electronic nose  for  rapid  diagnosis  of tuberculosis
Application of electronic nose for rapid diagnosis of tuberculosisAnkit Kumar Singh
 
094 spectroscopic fiber optic catheter
094 spectroscopic fiber optic catheter094 spectroscopic fiber optic catheter
094 spectroscopic fiber optic catheterSHAPE Society
 
Quality Measurements Using NIR/MIR Spectroscopy: A Rotten Apple Could Turn Yo...
Quality Measurements Using NIR/MIR Spectroscopy: A Rotten Apple Could Turn Yo...Quality Measurements Using NIR/MIR Spectroscopy: A Rotten Apple Could Turn Yo...
Quality Measurements Using NIR/MIR Spectroscopy: A Rotten Apple Could Turn Yo...TechRentals
 

Similar to 103100 (20)

151 performance of a localized fiber optic
151 performance of a localized fiber optic151 performance of a localized fiber optic
151 performance of a localized fiber optic
 
Nirs
NirsNirs
Nirs
 
151 performance of a localized fiber optic
151 performance of a localized fiber optic151 performance of a localized fiber optic
151 performance of a localized fiber optic
 
The performance of portable mid-infrared spectroscopy for the prediction of s...
The performance of portable mid-infrared spectroscopy for the prediction of s...The performance of portable mid-infrared spectroscopy for the prediction of s...
The performance of portable mid-infrared spectroscopy for the prediction of s...
 
Chemical Analysis Facility
Chemical Analysis FacilityChemical Analysis Facility
Chemical Analysis Facility
 
Lab on a chip
Lab on a chip Lab on a chip
Lab on a chip
 
Item 9 Standard Protocol and Scheme for Measuring Soil Spectroscopy under the...
Item 9 Standard Protocol and Scheme for Measuring Soil Spectroscopy under the...Item 9 Standard Protocol and Scheme for Measuring Soil Spectroscopy under the...
Item 9 Standard Protocol and Scheme for Measuring Soil Spectroscopy under the...
 
111
111111
111
 
Lab on chip copy
Lab on chip   copyLab on chip   copy
Lab on chip copy
 
محاضره نانو -دكتور عمر نور
محاضره نانو -دكتور عمر نور محاضره نانو -دكتور عمر نور
محاضره نانو -دكتور عمر نور
 
Recent advances in endodontics
Recent advances in endodontics Recent advances in endodontics
Recent advances in endodontics
 
How to give a written presentation. Conferences: Oral and poster communicatio...
How to give a written presentation.Conferences: Oral and poster communicatio...How to give a written presentation.Conferences: Oral and poster communicatio...
How to give a written presentation. Conferences: Oral and poster communicatio...
 
Measuring Nitrous Oxide & Methane from Feedyard Surfaces - the NFT-NSS Chambe...
Measuring Nitrous Oxide & Methane from Feedyard Surfaces - the NFT-NSS Chambe...Measuring Nitrous Oxide & Methane from Feedyard Surfaces - the NFT-NSS Chambe...
Measuring Nitrous Oxide & Methane from Feedyard Surfaces - the NFT-NSS Chambe...
 
Webinar jenck id_sustancias
Webinar jenck id_sustanciasWebinar jenck id_sustancias
Webinar jenck id_sustancias
 
giesy-gwf-omics.pptx
giesy-gwf-omics.pptxgiesy-gwf-omics.pptx
giesy-gwf-omics.pptx
 
Application of electronic nose for rapid diagnosis of tuberculosis
Application  of  electronic nose  for  rapid  diagnosis  of tuberculosisApplication  of  electronic nose  for  rapid  diagnosis  of tuberculosis
Application of electronic nose for rapid diagnosis of tuberculosis
 
Spectroscopic fiber optic catheter tania - aha 2001
Spectroscopic fiber optic catheter  tania - aha 2001Spectroscopic fiber optic catheter  tania - aha 2001
Spectroscopic fiber optic catheter tania - aha 2001
 
094 spectroscopic fiber optic catheter
094 spectroscopic fiber optic catheter094 spectroscopic fiber optic catheter
094 spectroscopic fiber optic catheter
 
094 spectroscopic fiber optic catheter
094 spectroscopic fiber optic catheter094 spectroscopic fiber optic catheter
094 spectroscopic fiber optic catheter
 
Quality Measurements Using NIR/MIR Spectroscopy: A Rotten Apple Could Turn Yo...
Quality Measurements Using NIR/MIR Spectroscopy: A Rotten Apple Could Turn Yo...Quality Measurements Using NIR/MIR Spectroscopy: A Rotten Apple Could Turn Yo...
Quality Measurements Using NIR/MIR Spectroscopy: A Rotten Apple Could Turn Yo...
 

More from SHAPE Society

Acc vp-org 3-02 stone
Acc vp-org 3-02 stoneAcc vp-org 3-02 stone
Acc vp-org 3-02 stoneSHAPE Society
 
101205 shape aha 2005 f
101205 shape aha 2005 f101205 shape aha 2005 f
101205 shape aha 2005 fSHAPE Society
 
Acc presentation macrophage (1)
Acc presentation macrophage (1)Acc presentation macrophage (1)
Acc presentation macrophage (1)SHAPE Society
 
Acc presentation (1)
Acc presentation (1)Acc presentation (1)
Acc presentation (1)SHAPE Society
 
Acc presentation lipid coated(2)
Acc presentation lipid coated(2)Acc presentation lipid coated(2)
Acc presentation lipid coated(2)SHAPE Society
 
Acc 2002 microarray mehran for print
Acc 2002 microarray mehran for printAcc 2002 microarray mehran for print
Acc 2002 microarray mehran for printSHAPE Society
 
Acc 2002 mehran for print
Acc 2002  mehran for printAcc 2002  mehran for print
Acc 2002 mehran for printSHAPE Society
 
Acc2002 thermography
Acc2002 thermographyAcc2002 thermography
Acc2002 thermographySHAPE Society
 
#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st centurySHAPE Society
 
A20 is an atherosclerosis
A20 is an atherosclerosisA20 is an atherosclerosis
A20 is an atherosclerosisSHAPE Society
 
259 crp as a risk factor
259 crp as a risk factor259 crp as a risk factor
259 crp as a risk factorSHAPE Society
 
511 first steps towards understanding
511 first steps towards understanding511 first steps towards understanding
511 first steps towards understandingSHAPE Society
 

More from SHAPE Society (20)

Barth imt
Barth imtBarth imt
Barth imt
 
Braunwald
BraunwaldBraunwald
Braunwald
 
Acc vp-org 3-02 stone
Acc vp-org 3-02 stoneAcc vp-org 3-02 stone
Acc vp-org 3-02 stone
 
101205 shape aha 2005 f
101205 shape aha 2005 f101205 shape aha 2005 f
101205 shape aha 2005 f
 
Acc v porg becker
Acc v porg beckerAcc v porg becker
Acc v porg becker
 
Acc presentation macrophage (1)
Acc presentation macrophage (1)Acc presentation macrophage (1)
Acc presentation macrophage (1)
 
Acc v porg
Acc v porgAcc v porg
Acc v porg
 
Acc presentation (1)
Acc presentation (1)Acc presentation (1)
Acc presentation (1)
 
Ac cculprit
Ac cculpritAc cculprit
Ac cculprit
 
Acc presentation lipid coated(2)
Acc presentation lipid coated(2)Acc presentation lipid coated(2)
Acc presentation lipid coated(2)
 
Acc 2002 microarray mehran for print
Acc 2002 microarray mehran for printAcc 2002 microarray mehran for print
Acc 2002 microarray mehran for print
 
Acc booth inventory
Acc booth inventoryAcc booth inventory
Acc booth inventory
 
Acc 04 vuln pt
Acc 04 vuln ptAcc 04 vuln pt
Acc 04 vuln pt
 
Acc 2002 mehran for print
Acc 2002  mehran for printAcc 2002  mehran for print
Acc 2002 mehran for print
 
Acc2002 thermography
Acc2002 thermographyAcc2002 thermography
Acc2002 thermography
 
A20 gene
A20 geneA20 gene
A20 gene
 
#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century
 
A20 is an atherosclerosis
A20 is an atherosclerosisA20 is an atherosclerosis
A20 is an atherosclerosis
 
259 crp as a risk factor
259 crp as a risk factor259 crp as a risk factor
259 crp as a risk factor
 
511 first steps towards understanding
511 first steps towards understanding511 first steps towards understanding
511 first steps towards understanding
 

Recently uploaded

CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxDr Bilal Natiq
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinethanaram patel
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfMyThaoAiDoan
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 

Recently uploaded (20)

CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicine
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 

103100

  • 1. Progress Report for NIR Spectroscopy Studies November 7, 2000 Tania Khan Mohammed Asif, M.D. Silvio Litovsky, M.D. Morteza Naghavi, M.D.
  • 2. Progress • New probe design being worked out with Multimode to improve NIR signal 10/31- current – Data analysis of all prior spectra required in progress – Characterize new light source in same manner (configurations, reference standards, sampling methods) – Must send out on order before AHA next week • Ongoing difficulties in working on a depth penetration study • Tissue phantom study needed for pH • Experimental setup issues: time, temperature, physiological maintenance, digital camera, etc.
  • 4. Data 1 2 3 4 5 0.1 mm thick pH 7.63 34.6°C0.3 mm thick pH 8.08 32.9°C 0.4 mm thick pH 7.41 32.5°C 0.6 mm thick pH 8.08 34.2°C Thrombosed/Calicified area? 0.6 x 0.5 cm 0.7 mm thick pH 8.25 32.1°C Calcified hard area
  • 6. HA-2-2 -0.4 -0.2 0.0 0.2 0.4 0.6 0.8 1.0 400 500 600 700 800 900 1000 1100 wavelength absorbance 4x 10x 40x
  • 7. HA-2-3 -0.4 -0.2 0.0 0.2 0.4 0.6 0.8 400 500 600 700 800 900 1000 1100 wavelength absorbance 4x 10x 40x
  • 8. HA-2-4 -0.4 -0.2 0.0 0.2 0.4 0.6 0.8 400 500 600 700 800 900 1000 1100 wavelength absorbance 4x 40x Very calcified, Should have put in De-Cal Solution more than 1 hr.
  • 9. HA-2-5 -0.4 -0.2 0.0 0.2 0.4 0.6 0.8 1.0 1.2 400 500 600 700 800 900 1000 1100 wavelength absorbance 4x 40x 10x
  • 10. All Areas -0.4 -0.2 0.0 0.2 0.4 0.6 0.8 1.0 1.2 400 500 600 700 800 900 1000 1100 wavelength absorbance VIS HA-2-5 I-M VIS HA-2-4 HA-2-3 VIS HA-2-2 HA-2-1 Fibrosis, necrosis, calcifications are all qualitative Only 5 points, no pH correlation can be made Environmental condition stabilization needs to be improved Quantify degree of surface roughness for spectra collection
  • 11. CONCLUSIONS • New light source changes relative absorbance – Light source must be characterized (configurations, reference standards, etc.) • Tissue penetration unresolved with histology – Penetration study must be completed with new light source • Histology and other experimental setup issues unresolved; temperature, other physiological, morphological variables • Need quantitative measurements of histology – Cap thickness, size of necrotic core, cell density, etc. • New probe needed to reach wavelengths above 1900 nm (lactate region) ; spectrometer OK – Currently being designed with help from Mulitmode Inc.
  • 12. PRIORITIES 1. Analyze data to see what would be best to incorporate in a new probe design to get better spectra out past 1900 nm (water bands, lactate bands, cholesterol bands) 2. Characterize light source 3. Conduct depth penetration study 4. Conduct tissue phantom study (pH, lactate, thrombus?) 5. Fix experimental setup issues 6. Start tissue pH spectroscopy of human carotid plaques study